Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.
Mã công tyPEN
Tên công tyPenumbra Inc
Ngày IPOSep 18, 2015
Được thành lập vào2004
CEOMr. Adam Elsesser, J.D.
Số lượng nhân viên4500
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhSep 18
Địa chỉOne Penumbra Place
Thành phốALAMEDA
Sàn giao dịch chứng khoánNYSE Consolidated
Quốc giaUnited States of America
Mã bưu điện94502
Điện thoại15109952486
Trang webhttps://www.penumbrainc.com/
Mã công tyPEN
Ngày IPOSep 18, 2015
Được thành lập vào2004
Tổng cộng
0.00
USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.

Không có dữ liệu